Skip to main content
Premium Trial:

Request an Annual Quote

Ulrich Mueller

Ulrich Mueller has joined Sengine Precision Medicine as its chief business officer, effective Nov. 1. He previously was COO of Bio-Path Holding. Before that, he served as vice president of industry relation and clinical research support at the Fred Hutchinson Cancer Research Center and was managing director of technology commercialization at the University of Texas MD Anderson Cancer Center. 

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.